J1I-MC-GZQD
ASO Keyword Dashboard
Tracking 20 keywords for J1I-MC-GZQD in Google Play
J1I-MC-GZQD tracks 20 keywords (no keywords rank yet; 20 need traction). Key metrics: opportunity 70.9, difficulty 40.3.
This app is for participants in the medical study for Lilly J1I-MC-GZQD only
Tracked keywords
20
0 ranked • 20 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
70.9
Top keyword: participants
Avg difficulty
40.3
Lower scores indicate easier wins
Opportunity leaders
- 60.8
participants
Opportunity: 74.0 • Difficulty: 36.9 • Rank —
Competitors: 78
- 59.3
controlled
Opportunity: 74.0 • Difficulty: 38.3 • Rank —
Competitors: 200
- 58.1
phase
Opportunity: 73.0 • Difficulty: 36.4 • Rank —
Competitors: 157
- 67.4
exclusively
Opportunity: 73.0 • Difficulty: 41.6 • Rank —
Competitors: 396
- 56.9
pain
Opportunity: 73.0 • Difficulty: 35.3 • Rank —
Competitors: 105
Unranked opportunities
participants
Opportunity: 74.0 • Difficulty: 36.9 • Competitors: 78
controlled
Opportunity: 74.0 • Difficulty: 38.3 • Competitors: 200
phase
Opportunity: 73.0 • Difficulty: 36.4 • Competitors: 157
exclusively
Opportunity: 73.0 • Difficulty: 41.6 • Competitors: 396
pain
Opportunity: 73.0 • Difficulty: 35.3 • Competitors: 105
High competition keywords
allows
Total apps: 177,711 • Major competitors: 5,773
Latest rank: — • Difficulty: 53.4
complete
Total apps: 169,116 • Major competitors: 8,785
Latest rank: — • Difficulty: 53.7
created
Total apps: 55,816 • Major competitors: 1,989
Latest rank: — • Difficulty: 48.2
study
Total apps: 53,695 • Major competitors: 1,147
Latest rank: — • Difficulty: 48.0
back
Total apps: 53,024 • Major competitors: 3,343
Latest rank: — • Difficulty: 54.4
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| medical | 71 | 100 | 44 | 72 33,909 competing apps Median installs: 1,039 Avg rating: 1.9 | — | — | 840 major competitor apps |
| created | 70 | 100 | 48 | 76 55,816 competing apps Median installs: 1,592 Avg rating: 2.0 | — | — | 1,989 major competitor apps |
| complete | 67 | 100 | 54 | 83 169,116 competing apps Median installs: 2,111 Avg rating: 2.0 | — | — | 8,785 major competitor apps |
| allows | 67 | 100 | 53 | 84 177,711 competing apps Median installs: 1,248 Avg rating: 1.9 | — | — | 5,773 major competitor apps |
| back | 70 | 100 | 54 | 75 53,024 competing apps Median installs: 2,847 Avg rating: 2.2 | — | — | 3,343 major competitor apps |
| low | 72 | 100 | 50 | 70 26,657 competing apps Median installs: 3,346 Avg rating: 2.2 | — | — | 1,709 major competitor apps |
| participants | 74 | 100 | 37 | 61 6,527 competing apps Median installs: 531 Avg rating: 1.8 | — | — | 78 major competitor apps |
| phase | 73 | 100 | 36 | 58 4,477 competing apps Median installs: 908 Avg rating: 1.9 | — | — | 157 major competitor apps |
| exclusively | 73 | 100 | 42 | 67 17,094 competing apps Median installs: 647 Avg rating: 1.7 | — | — | 396 major competitor apps |
| study | 70 | 100 | 48 | 75 53,695 competing apps Median installs: 1,121 Avg rating: 1.8 | — | — | 1,147 major competitor apps |
| pain | 73 | 100 | 35 | 57 3,749 competing apps Median installs: 1,614 Avg rating: 2.0 | — | — | 105 major competitor apps |
| weekly | 72 | 100 | 47 | 71 27,673 competing apps Median installs: 1,006 Avg rating: 2.1 | — | — | 1,471 major competitor apps |
| safety | 71 | 100 | 53 | 73 36,993 competing apps Median installs: 982 Avg rating: 1.8 | — | — | 1,246 major competitor apps |
| investigate | 72 | 100 | 34 | 51 1,515 competing apps Median installs: 8,823 Avg rating: 2.7 | — | — | 115 major competitor apps |
| controlled | 74 | 100 | 38 | 59 5,309 competing apps Median installs: 1,916 Avg rating: 1.9 | — | — | 200 major competitor apps |
| chronic | 72 | 100 | 32 | 54 2,326 competing apps Median installs: 960 Avg rating: 2.0 | — | — | 37 major competitor apps |
| efficacy | 70 | 100 | 26 | 42 443 competing apps Median installs: 192 Avg rating: 1.6 | — | — | 5 major competitor apps |
| back pain | 69 | 100 | 25 | 39 261 competing apps Median installs: 3,107 Avg rating: 2.0 | — | — | 12 major competitor apps |
| obesity | 69 | 100 | 25 | 40 345 competing apps Median installs: 710 Avg rating: 1.7 | — | — | 4 major competitor apps |
| overweight | 69 | 100 | 24 | 38 254 competing apps Median installs: 905 Avg rating: 1.8 | — | — | 8 major competitor apps |
App Description
This app is for participants in the medical study for Lilly J1I-MC-GZQD only
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain (TRIUMPH-7)